Jonathan Monson - Dec 1, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/4/2023, 05:42 PM
Previous filing
Aug 3, 2023
Next filing
Feb 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +3.56K $0.00 3.56K Dec 1, 2023 Common Stock 3.56K Direct F1, F2
transaction BSX Stock Option (Right to Buy) Award $0 +10.5K $0.00 10.5K Dec 1, 2023 Common Stock 10.5K $56.14 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in full on December 1, 2026, the third anniversary of the date of grant.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in full on December 1, 2026, the third anniversary of the date of grant.